ZS PHARMA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 71
- Market Cap
- -
- Website
- http://zspharma.com
Clinical Trials
8
Active:0
Completed:7
Trial Phases
3 Phases
Phase 2:1
Phase 3:4
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (66.7%)Phase 2
1 (16.7%)Phase 4
1 (16.7%)POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study
Completed
- Conditions
- Hyperkalemia
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT02609841
REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study
Completed
- Conditions
- Hyperkalemia
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT02607085
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
- First Posted Date
- 2014-06-13
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 751
- Registration Number
- NCT02163499
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT02107092
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
Phase 3
Completed
- Conditions
- Hyperkalemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 258
- Registration Number
- NCT02088073
- Prev
- 1
- 2
- Next
News
No news found